Alembic Pharmaceuticals Management
Management criteria checks 3/4
Alembic Pharmaceuticals' CEO is Chirayu Amin, appointed in Apr 2016, has a tenure of 13.83 years. total yearly compensation is ₹88.00M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 2.13% of the company’s shares, worth ₹4.19B. The average tenure of the management team and the board of directors is 8.5 years and 10 years respectively.
Key information
Chirayu Amin
Chief executive officer
₹88.0m
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 8yrs |
| CEO ownership | 2.1% |
| Management average tenure | 8.5yrs |
| Board average tenure | 10yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | ₹6b |
| Sep 30 2023 | n/a | n/a | ₹5b |
| Jun 30 2023 | n/a | n/a | ₹5b |
| Mar 31 2023 | ₹88m | ₹88m | ₹3b |
| Dec 31 2022 | n/a | n/a | ₹2b |
| Sep 30 2022 | n/a | n/a | ₹3b |
| Jun 30 2022 | n/a | n/a | ₹3b |
| Mar 31 2022 | ₹280m | ₹80m | ₹5b |
| Dec 31 2021 | n/a | n/a | ₹8b |
| Sep 30 2021 | n/a | n/a | ₹9b |
| Jun 30 2021 | n/a | n/a | ₹10b |
| Mar 31 2021 | ₹315m | ₹65m | ₹11b |
| Dec 31 2020 | n/a | n/a | ₹12b |
| Sep 30 2020 | n/a | n/a | ₹11b |
| Jun 30 2020 | n/a | n/a | ₹10b |
| Mar 31 2020 | ₹265m | ₹65m | ₹8b |
| Dec 31 2019 | n/a | n/a | ₹7b |
| Sep 30 2019 | n/a | n/a | ₹7b |
| Jun 30 2019 | n/a | n/a | ₹6b |
| Mar 31 2019 | ₹255m | ₹55m | ₹6b |
| Dec 31 2018 | n/a | n/a | ₹6b |
| Sep 30 2018 | n/a | n/a | ₹5b |
| Jun 30 2018 | n/a | n/a | ₹4b |
| Mar 31 2018 | ₹220m | ₹55m | ₹4b |
Compensation vs Market: Chirayu's total compensation ($USD1.05M) is above average for companies of similar size in the Indian market ($USD420.57K).
Compensation vs Earnings: Chirayu's compensation has been consistent with company performance over the past year.
CEO
Chirayu Amin (77 yo)
8yrs
Tenure
₹88,000,000
Compensation
Mr. Chirayu Ramanbhai Amin, M.B.A. (U.S.A.), has been Chief Executive Officer of Alembic Pharmaceuticals Limited since April 27, 2016. Mr. Amin served as Managing Director of Alembic Pharmaceuticals Limite...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & CEO | 8yrs | ₹88.00m | 2.13% ₹ 4.2b | |
| MD & Executive Director | 9yrs | ₹122.20m | 0.59% ₹ 1.2b | |
| MD & Executive Director | 9yrs | ₹122.20m | 0.51% ₹ 1.0b | |
| Director of Finance | no data | ₹56.90m | no data | |
| President of Operations | no data | no data | no data | |
| Chief Scientific Officer | no data | ₹8.41m | no data | |
| Company Secretary & Compliance Officer | less than a year | no data | no data | |
| Chief Business Development Officer | no data | ₹8.30m | 0.51% ₹ 1.0b | |
| Senior Vice President of Human Resources | no data | no data | no data | |
| Senior Vice President | no data | ₹8.12m | no data | |
| Senior Vice President of Finance | no data | ₹9.20m | no data | |
| Senior Vice President of Supply Chain | no data | no data | no data |
8.5yrs
Average Tenure
62.5yo
Average Age
Experienced Management: 533573's management team is seasoned and experienced (8.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & CEO | 13.8yrs | ₹88.00m | 2.13% ₹ 4.2b | |
| MD & Executive Director | 13.1yrs | ₹122.20m | 0.59% ₹ 1.2b | |
| MD & Executive Director | 10.9yrs | ₹122.20m | 0.51% ₹ 1.0b | |
| Director of Finance | 13.8yrs | ₹56.90m | no data | |
| Independent Non-Executive Director | 9.2yrs | ₹1.83m | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | 2.2yrs | ₹1.82m | no data | |
| Additional Independent Director | less than a year | no data | no data |
10.0yrs
Average Tenure
56.5yo
Average Age
Experienced Board: 533573's board of directors are seasoned and experienced ( 10 years average tenure).